{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["14(3)"],"submitter":["Matsuoka T"],"journal":["Translational cancer research"],"pagination":["1507-1510"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11985196"],"repository":["biostudies-literature"],"pubmed_title":["The predictive value of HER2DX assay with pathological response and prognosis in patients with early HER2-positive breast cancers: commentary on the PHERGain trial."],"pmcid":["PMC11985196"],"pubmed_authors":["Yamamoto Y","Matsuoka T","Yashiro M"],"additional_accession":[]},"is_claimable":false,"name":"The predictive value of HER2DX assay with pathological response and prognosis in patients with early HER2-positive breast cancers: commentary on the PHERGain trial.","description":null,"dates":{"release":"2025-01-01T00:00:00Z","publication":"2025 Mar","modification":"2026-06-01T08:55:42.695Z","creation":"2025-07-10T03:08:05.082Z"},"accession":"S-EPMC11985196","cross_references":{"pubmed":["40224980"],"doi":["10.21037/tcr-2024-2421"]}}